4.4 Article

Feature article: LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice

Wei Qin et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Editorial Material Cardiac & Cardiovascular Systems

LCZ696 (Sacubitril/Valsartan) Can We Predict Who Will Benefit?

G. William Dec

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Pharmacology & Pharmacy

The potential role of valsartan+AHU377 (LCZ696) in the treatment of heart failure

Adriaan A. Voors et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)

Review Pharmacology & Pharmacy

Oxidative stress: a key contributor to diabetic cardiomyopathy

Madhu Khullar et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy

Dirk Westermann et al.

BASIC RESEARCH IN CARDIOLOGY (2007)